Document:

Exhibit
        10.30

      Schedule
        Identifying Similar Non-Dilutive Promissory Notes

      

      

      The
        below
        described notes are in the form of the Promissory Note set forth in Exhibit
        10.28 above. 

       

      
        	
                 

                Date
                  of Issuance

              	 	
                Original

                Principal
                  Amount

              	 	
                Current

                Maturity
                  Date

              
	 	 	 	 	 
	
                August
                  16, 2005

              	 	
                $45,000(1)

              	 	
                December
                  30, 2005(2)

              
	
                September
                  26, 2005

              	 	
                $25,000

              	 	
                September
                  26, 2006

              
	
                November
                  1, 2005

              	 	
                $20,000

              	 	
                May
                  3, 2007

              

      

      ____________

      (1)    Outstanding
        principal reduced to $40,000 as a result of a $5,000 payment made on September
        6, 2005.

      

      (2)    As
        previously and currently extended.Exhibit
        10.31

      Form
        of Allonge

      

      

      

      

      THIS
        ALLONGE
        to the
        Promissory Note (the “Note”) in the original principal sum of $__________, dated
        ______________, 200__, made by Marc Pharmaceuticals, Inc., payable to
        __________________hereby amends the Note to provide that its maturity date
        shall
        be extended from ________________, 200_ to _____________, 200_.

      

      All
        other
        terms of the Note shall remain in full force and effect.

      

      This
        Allonge shall be attached to the Note and is hereby made a part
        thereof.

      

      This
        Allonge may be signed in counterparts, both of which taken together shall
        constitute one and the same instrument.

      

      Dated:
        ____________________________

      

      

      

      ___________________________

      

      

      

      Acknowledged
        and agreed:

      

      MARC
        PHARMACEUTICALS, INC.

      

      By:____________________________

      Name:
        Robert M. Cohen

      Title:
        PresidentExhibit
        10.32

      Schedule
        Identifying Similar Allonges

      

      

      Certain
        lenders of debt that was outstanding as of the dates set forth below have
        agreed
        to extend the respective maturity dates of their loans until June 30, 2006,
        except as otherwise indicated, pursuant to Allonges substantially similar
        to the
        Form of Allonge set forth in Exhibit 10.31.

      

      
        	
                 

                Date
                  of Issuance

              	 	
                 

                Amount

              	 	
                Original

                Maturity
                  Date

              
	
                November
                  7, 2003

              	 	
                $25,000

              	 	
                November
                  7, 2004

              
	
                February
                  3, 2004

              	 	
                $25,000

              	 	
                February
                  3, 2005

              
	
                February
                  7, 2004

              	 	
                $25,000

              	 	
                February
                  7, 2005

              
	
                February
                  9, 2004

              	 	
                $25,000

              	 	
                February
                  9, 2005

              
	
                March
                  22, 2004

              	 	
                $25,000

              	 	
                March
                  22, 2005

              
	
                March
                  23, 2004

              	 	
                $75,000

              	 	
                March
                  23, 2005

              
	
                March
                  23, 2004

              	 	
                $25,000

              	 	
                March
                  23, 2005

              
	
                May
                  28, 2004

              	 	
                $50,000

              	 	
                May
                  28, 2005

              
	
                May
                  31, 2004

              	 	
                $10,000

              	 	
                May
                  31, 2005

              
	
                June
                  10, 2004

              	 	
                $15,000

              	 	
                June
                  10, 2005

              
	
                June
                  25, 2004

              	 	
                $500,000

              	 	
                June
                  25, 2005

              
	
                August
                  16, 2005

              	 	
                $45,000 

              	 	
                September
                  16, 2005(1)

              

      

      

      ____________

      (1)    Extended
        until December 30, 2005FIRST AMENDMENT
                                     TO THE
                                MERGER AGREEMENT
                                  BY AND AMONG
                     AFRICAN AMERICAN MEDICAL NETWORK, INC.;
                   AFMN, INC.; MEDICAL MEDIA TELEVISION, INC.;
                         AND AAMN ACQUISITION SUB, INC.

      This First Amendment to the Merger Agreement (the "Amendment") dated
November 16, 2005, is by and among African American Medical Network, Inc., a
company duly organized and existing under the laws of the State of Florida,
having a place of business located at 6601 Center Drive West, Suite 521, Los
Angeles, California 90045 (hereinafter referred to as "Target Company"); AFMN,
Inc., a company duly organized and existing under the laws of the State of
Delaware, having a place of business located at 6601 Center Drive West, Suite
521, Los Angeles, California 90045 (hereinafter referred to as AFMN); Medical
Media Television, Inc. f/k/a PetCARE Television Network, Inc., a company duly
organized and existing under the laws of the State of Florida, having a place of
business located at 8406 Benjamin Road, Suite C, Tampa, Florida 33634
(hereinafter referred to as "Medical Media"); and AAMN Acquisition Sub, Inc., a
company duly organized and existing under the laws of the State of Florida,
having a place of business located at 8406 Benjamin Road, Suite C, Tampa,
Florida 33634 (hereinafter referred to as "Acquisition Sub").

                             BACKGROUND INFORMATION

      The parties to this Amendment entered into a Merger Agreement effective
May 11, 2005 (the "Merger Agreement"). The parties now wish to amend that
agreement, retroactive to the date the Merger Agreement was consummated.
Capitalized terms used herein shall have the meaning ascribed to them in the
Merger Agreement unless otherwise set forth herein. Accordingly, in
consideration of the promises contained herein, the parties agree as follows:

                              OPERATIVE PROVISIONS

      1. Amendment to Recitals. The Recitals are amended by deleting the present
form of the Recitals in their entirety and by substituting, in lieu thereof, the
following:

            "WHEREAS, Medical Media desires to acquire one hundred percent
      (100%) of the capital stock of Target Company by issuing 19,415,626 shares
      of the common stock of Medical Media to AFMN;

            WHEREAS, in order to accomplish the above and enable AFMN to receive
      the shares of Medical Media without having to recognize income for federal
      income tax purposes, the acquisition of Target Company is being structured
      as a "reverse triangular merger," intended to qualify as a tax-free
      reorganization within the meaning of Section 368(a)(2)(E) of the Internal
      Revenue Code of 1986, as amended (the "Code");

            WHEREAS, the respective Boards of Directors of Medical Media,
      Acquisition Sub, and Target Company have determined that it is in the best
      interests of their respective companies and stockholders that Acquisition
      Sub merge with and into Target Company (the "Merger") with Target Company
      being the surviving corporation;

<PAGE>

            WHEREAS, Medical Media, as the sole stockholder of Acquisition Sub,
      and AFMN, as the sole stockholder of Target Company, have approved this
      Agreement, the Merger and the transactions contemplated by this Agreement
      pursuant to action taken by written consent in accordance with the
      requirements of the Florida Business Corporation Act ("FBCA") and the
      requirements of Delaware General Corporation Law ("DGCL");

            WHEREAS, pursuant to the terms and conditions set forth herein,
      Acquisition Sub will be merged with and into Target Company, and AFMN will
      receive 19,415,626 shares of the common stock of Medical Media in exchange
      for all of AFMN's shares of the capital stock of Target Company.

            NOW THEREFORE, the parties hereto hereby agree as follows:"

      2. Amendment to Article 2, Section 2.1. Article 2, Section 2.1 is amended
by deleting the present form of Article 2, Section 2.1 in its entirety and by
substituting, in lieu thereof, the following:

      "The Merger Consideration. As of the Effective Date (as defined in Section
      3.2 below) and as a result of the Merger and without any other action on
      the part of the stockholders, AFMN shall receive 19,415,626 shares of the
      authorized, but previously unissued, common capital stock of Medical Media
      (the "Medical Media Shares") in exchange for all of the issued and
      outstanding capital stock of Target Company. Additionally, as of the
      Effective Date of the Merger, (i) all issued and outstanding convertible
      securities of AFMN as set forth on Schedule 2.1(i) shall be exchanged for
      equivalent convertible securities of Medical Media on a one for one basis
      and (ii) all issued and outstanding warrants to purchase AFMN common stock
      set forth on Schedule 2.1(i) shall be exchanged for equivalent Medical
      Media warrants on a one for one basis. All convertible securities and
      warrants exchanged pursuant to this Section 2.1 shall be governed by the
      same terms and conditions as were applicable to the securities prior to
      the Effective Date of the Merger."

      3. Amendment to Article 3, Section 3.1. Article 3, Section 3.1 is amended
by deleting the present form of Article 3, Section 3.1 in its entirety and by
substituting, in lieu thereof, the following:

      "Closing. The closing contemplated by Sections 1.1 and 2.1 above (the
      "Closing") shall be held at the offices of Medical Media, 8406 Benjamin
      Road, Suite C, Tampa, FL 33634; on the 16 day of November, 2005 at 10:00
      a.m., unless another place or time is agreed upon in writing by the
      parties (the "Closing Date")."

                                       2
<PAGE>

      4. Amendment to Article 3, Section 3.2. Article 3, Section 3.2 is amended
by deleting the present form of Article 3, Section 3.2 in its entirety and by
substituting, in lieu thereof, the following:

      "Effective Date of Merger. After the Closing, the Articles of Merger
      executed by the parties on the Closing Date shall be immediately submitted
      for filing with the Secretary of State of the State of Florida. The date
      of such filing shall be the effective date of the Merger (the "Effective
      Date")."

      5. Amendment to Article 4, Section 4.1. Article 4, Section 4.1 is amended
by deleting the present form of Article 4, Section 4.1 in its entirety and by
substituting, in lieu thereof, the following:

      "Registration Statement. Medical Media hereby agrees to file, as soon as
      practicable after the execution of this Agreement, an appropriate
      registration statement ("Registration Statement") with the Securities and
      Exchange Commission registering for sale the Medical Media Shares. AFMN
      hereby agrees that, as soon as practicable after the effectiveness of the
      Registration Statement, AFMN will distribute the Medical Media Shares to
      the AFMN shareholders of record as of the Effective Date on a pro-rata
      basis pursuant to the Capital Stock Escrow and Disposition Agreement
      attached as Schedule 4.1; provided, however, the Medical Media Shares
      distributed by AFMN will have the same characteristics as the shares held
      by the AFMN shareholders as of the Closing Date of this Agreement, i.e.,
      if a shareholder has restricted shares of AFMN then such shareholder will
      receive restricted shares of Medical Media (regardless of registration),
      and likewise if a shareholder has unrestricted shares of AFMN then such
      shareholder will receive unrestricted shares of Medical Media. AFMN hereby
      acknowledges that, at Medical Media's option, shares underlying
      convertible preferred shares, convertible debentures, warrants, or options
      outstanding as of the Closing Date also will be registered pursuant to the
      Registration Statement. AFMN further agrees that, prior to the
      effectiveness of the Registration Statement, all voting and consensual
      rights with respect to the Medical Media Shares shall vest with Philip M.
      Cohen."

      6. Amendment to Article 4, Section 4.2. Article 4, Section 4.2 is amended
by deleting the present form of Article 4, Section 4.2 in its entirety and by
substituting, in lieu thereof, the following:

      "Board of Directors of Medical Media; Target Company and Newco.

            (a) On the Closing Date, shareholders of Medical Media will execute
      a Written Action in Lieu of Special Meeting of Shareholders to elect
      Philip M. Cohen (Chairman of the Board), J. Holt Smith, Charles V.
      Richardson, Randall Maxey, Bernard Kouma, and Jeffrey I. Werber to serve
      as members of its Board of Directors until December 31, 2006.

            (b) On the Closing Date, shareholders of Newco (as defined in
      Section 4.4(a) hereof) will execute a Written Action in Lieu of Special
      Meeting of Shareholders to elect Philip M. Cohen (Chairman of the Board),
      J. Holt Smith, Bernard Kouma, and Jeffrey I. Werber to serve as members of
      its Board of Directors until December 31, 2006.

                                       3
<PAGE>

            (c) On the Closing Date, shareholders of Target Company will execute
      a Written Action in Lieu of Special Meeting of Shareholders to elect
      Philip M. Cohen (Chairman of the Board), J. Holt Smith, Charles V.
      Richardson, and Randall Maxey to serve as members of its Board of
      Directors until December 31, 2006."

      7. Amendment to Article 4, Section 4.4(c). Article 4, Section 4.4(c) is
amended by deleting the present form of Article 4, Section 4.4(c) in its
entirety and by substituting, in lieu thereof, the following:

      "(c) Payment of Obligations. AFMN acknowledges the existence of the
      following obligations and understands that Medical Media will satisfy
      these liabilities as soon as practicable after the Closing Date:

            (i) Promissory Note dated May 16, 2002 by and between PetCARE
            Television Network, Inc. and James Calaway in the principal amount
            of $100,000. The parties agree the current balance on this
            obligation is $91,500.

            (ii) Promissory Note dated June 7, 2002 by and between PetCARE
            Television Network, Inc. and Daniel V. Hugo in the principal amount
            of $25,000. The parties agree the current balance on this obligation
            is $25,000.

            (iii) Promissory Note dated June 5, 2002 by and between PetCARE
            Television Network, Inc. and Robert and Janna Hugo in the principal
            amount of $6,000. The parties agree the current balance on this
            obligation is $6,000.

            (iv) Promissory Note dated June 5, 2002 by and between PetCARE
            Television Network, Inc. and Robert and Jamie Turner in the
            principal amount of $5,000. The parties agree the current balance on
            this obligation is $5,000."

      8. Amendment to Article 5, Section 5.2. Article 5, Section 5.2 is amended
by deleting the present form of Article 5, Section 5.2 in its entirety and by
substituting, in lieu thereof, the following:

      "Each of Target Company and AFMN has the requisite corporate power and
      authority to enter into this Agreement and to carry out its respective
      obligations hereunder. The execution and delivery of this Agreement and
      the consummation of the transactions contemplated hereby have been duly
      authorized and approved by the Board of Directors of Target Company and
      AFMN and the shareholder of Target Company; and no other corporate
      proceedings on the part of Target Company or AFMN is necessary to approve
      and adopt this Agreement or to approve the consummation of the Merger
      contemplated hereby. This Agreement has been duly and validly executed and
      delivered by Target Company and AFMN and constitutes a valid and binding
      agreement of Target Company and AFMN, enforceable in accordance with its
      terms."

                                       4
<PAGE>

      9. Amendment to Schedule 5.9. Schedule 5.9 is amended by deleting the
present form of Schedule 5.9 in its entirety and by substituting, in lieu
thereof, the attached Schedule 5.9.

      10. Amendment to Article 8, Section 8.2. Article 8, Section 8.2 is amended
by deleting the present form of Article 8, Section 8.2 in its entirety and by
substituting, in lieu thereof, the following:

      "Obligation of Target Company and AFMN to Close. The obligation of Target
      Company and AFMN to consummate the Merger contemplated by this Agreement
      on the Closing Date shall be subject to the satisfaction of the following
      conditions on or prior to the Closing Date:

            (a) Representations and Warranties; Compliance with Agreement. The
      representations and warranties of Medical Media and Acquisition Sub set
      forth in this Agreement shall be true and correct in all material respects
      as of the date of this Agreement and as of the Closing Date as though made
      on the Closing Date, and Medical Media and Acquisition Sub shall have
      performed all covenants and agreements to be performed by it under this
      Agreement on or prior to the Closing Date, and Medical Media and
      Acquisition Sub shall have delivered to AFMN certificates to such effect
      dated as of the Closing Date and signed by Medical Media and Acquisition
      Sub.

            (b) Litigation Affecting Closing. On the Closing Date, no proceeding
      shall be pending or threatened before any court or governmental agency in
      which it is sought to restrain or prohibit or to obtain damages or other
      relief in connection with this Agreement or the consummation of the
      transaction contemplated hereby, and no investigation that might eventuate
      in any such suit, action or proceeding shall be pending or threatened."

      11. Issuance of Convertible Debenture and Series A Warrant. On July 19,
2005, AFMN issued to Vicis Capital Master Fund that certain Series A Convertible
Debenture in the principal amount of Four Hundred Twelve Thousand and No/100
Dollars ($412,000) (the "Convertible Debenture"), the Series A Common Stock
Purchase Warrant (the "Series A Warrant"), and the Series B Common Stock
Purchase Warrant (the "Series B Warrant"). Medical Media does not object to the
issuance of the Convertible Debenture, the Series A Warrant, and the Series B
Warrant and herby consents to the amendment of Schedule 5.4 of the Merger
Agreement to reflect such issuance. A copy of Schedule 5.4, as amended, is
attached hereto.

      12. Reconfirmation of Agreement. All other aspects of the Merger Agreement
and any document referenced therein shall remain in full force and effect.

                                       5
<PAGE>

      In witness whereof, the parties have executed this Amendment on the date
first above written.

                                Medical Media Television, Inc. f/k/a
                                PetCARE Television Network, Inc.

                                By:  /s/ Philip M. Cohen
                                     ------------------------------------
                                     Philip M. Cohen, President

                                AAMN Acquisition Sub, Inc.

                                By:  /s/ Philip M. Cohen
                                     ------------------------------------
                                     Philip M. Cohen, President

                                African American Medical Network, Inc.

                                By:  /s/ Charles V. Richardson
                                     ------------------------------------
                                     Charles V. Richardson, President

                                AFMN, Inc.

                                By:  /s/ Charles V. Richardson
                                     ------------------------------------
                                     Charles V. Richardson, President

        [SIGNATURE PAGE FOR THE FIRST AMENDMENT TO THE MERGER AGREEMENT]

                                       6

<PAGE>

                                 SCHEDULE 2.1(i)

ISSUED AND OUTSTANDING CONVERTIBLE SECURITES OF AFMN, INC.

1.    Interest Bearing Single-Payment Promissory Note dated December 15, 2004
      for $200,000 issued to Carmen Bernstein ("Bernstein Note") which is
      convertible into 200,000 shares of AFMN's Common Stock.

2.    Interest Bearing Single-Payment Promissory Note dated April 18, 2005 for
      $100,000 issued to Laurence Wallace ("Wallace Note") which is convertible
      into 100,000 shares of AFMN's Common Stock.

3.    Series A Convertible Debenture dated July 19, 2005 for $412,000 issued to
      Vicis Capital Master Fund ("Series A Debenture") which is convertible into
      AFMN's Common Stock at twenty cents ($0.20) per share, as well as the
      accompanying (i) five-year Series A Common Stock Purchase Warrants to
      purchase 1,030,000 shares at $0.40 per share, and (ii) five-year Series B
      Common Stock Purchase Warrants to purchase 2,060,000 shares at $.030 per
      share.

ISSUED AND OUTSTANDING OPTIONS AND WARRANTS OF AFMN, INC.

4.    Debt Conversion Agreement under which the Bernstein Note can be converted
      into the 200,000 shares of AFMN's Common Stock mentioned in item 1 above
      and three-year warrants to purchase 200,000 shares of common stock of AFMN
      at $2.00 per share.

5.    Debt Conversion Agreement under which the Wallace Note can be converted
      into the 100,000 shares of AFMN's Common Stock mentioned in item 2 above
      and three-year warrants to purchase 50,000 shares of common stock of AFMN
      at $1.00 per share.

6.    Series A Common Stock Purchase Warrant issued to Vicis Master Capital Fund
      to purchase 1,030,000 shares of AFMN's Common Stock for five years at
      $0.40 per share.

7.    Series B Common Stock Purchase Warrant issued to Vicis Master Capital Fund
      to purchase 2,060,000 shares of AFMN's Common Stock for five years at
      $.0.30 per share.

                                       7

<PAGE>

                              AMENDED SCHEDULE 5.4

                        CAPITALIZATION OF TARGET COMPANY

Common Shares Authorized:           25,000,000
Common Shares Outstanding:               1,000

Preferred Shares Authorized:         5,000,000
Preferred Shares Outstanding:                0

              OUTSTANDING OPTIONS, WARRANTS, CONVERSION PRIVILEGES,
         SUBSCRIPTIONS, CALLS, COMMITMENTS OR RIGHTS OF TARGET COMPANY

None.

                SHAREHOLDERS OF TARGET COMPANY AS OF CLOSING DATE

The sole shareholder of the Target Company is AFMN, Inc. which owns 1,000
shares.

                                       8

<PAGE>

                              AMENDED SCHEDULE 5.9

                             CERTAIN TAX LIABILITIES

Payroll taxes for African American Medical Network, Inc.     $17,800.00

                                       9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}]]